IDNAPTEX
LIVE

Serial Number

79432740

Owner

ID SOLUTIONS

Attorney

Dianne M. Smith-Misemer

Filing Date

Jun 19, 2025

Add to watchlist:

No watchlists yet
View on USPTO

IDNAPTEX Trademark

Serial Number: 79432740

IDNAPTEX is a trademark filed by ID SOLUTIONS on June 19, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

ID SOLUTIONS (2 trademarks)

585 RUE DE LA CROIX VERTE

Entity Type: 98

Trademark Details

Filing Date

June 19, 2025

Registration Date

Not Registered

Published for Opposition

July 21, 2026

Goods & Services

Pharmaceutical products for the prevention and treatment of cancers; preparations and reagents for diagnosis for medical or veterinary use for use in detecting cancers, in vitro diagnosis, testing blood samples; diagnostic materials being diagnostic preparations for medical or veterinary use; reagents for medical use; chemical reagents for medical or veterinary use; organic reagents for medical or veterinary use; Medical diagnostic reagents for analysis of bodily fluids for medical use; reagents for diagnostic tests for medical use; reagents for genetic testing in medicine for medical use; reagents for in vitro use in laboratories for medical use; in vitro diagnostic preparation for medical use; Biological indicators for medical diagnosis of cancers; diagnostic substances for medical use; diagnostic biomarking reagents for medical use; diagnostic test kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, for detecting gene mutations implicated in cancers; in vitro test kits for detecting genetic defects; chemical preparations intended for use in DNA analysis for medical use; genetic identity tests comprising reagents for medical use; preparations for detecting genetic predispositions for medical use; reagents for nucleic acid amplification for medical use; diagnostic material being diagnostic preparations for medical and veterinary use

Diagnostic preparations and reagents other than for medical and veterinary use; Diagnostic screening agents for in-vitro diagnosis for scientific use; diagnostic reagents other than for medical use sold in kit form; diagnostic reagents for in-vitro use other than for medical or veterinary use; reagents for in-vitro laboratory uses other than for medical and veterinary use; chemical preparations intended for use in DNA analysis, other than for medical use; enzymes, other than for medical or veterinary use, for continuous, homogeneous and isothermal amplification processes for DNA-specific models; chemical genetic identity tests comprised of reagents for non-medical purposes; reagents for nucleic acid amplification other than for medical or veterinary use

Apparatus, and instruments for medical diagnosis, namely, cancer diagnosis; DNA and RNA testing apparatus for medical use; genetic testing apparatus for medical use; quantitative polymerase chain reaction (PCR) instrument for medical use, namely, thermal cycler; samplers for medical use, namely, sample preparation device for medical diagnostic use

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jul 21, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 15, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 18, 2026 TROA
REFUSAL PROCESSED BY IB
Jan 8, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 20, 2025 RFCS
REFUSAL PROCESSED BY MPU
Dec 20, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 14, 2025 RFCR
NON-FINAL ACTION WRITTEN
Nov 13, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 6, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 19, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 19, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 18, 2025 REPR